Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 201 participants.

Also called NCT04491136

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 201 participants (enrolled count) (from the registry)
Sponsor
  • Novartis Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04491136
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT04491136. Allocation not applicable; no masking; primary purpose treatment. Start 2020-11-11 (actual); primary completion 2023-06-08 (actual). Results posted on 2024-10-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)
Acronym
RHYTHM
Condition
Heart Failure
Intervention (Drug)
ACEI/ARB
Intervention (Drug)
ARNI
Lead sponsor
Novartis Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct04491136
Content hash
ecb8c95fcbc6aa15ccd5b3fafe906e80a41122cc50f569c0c16e3118e804c43d